CLINICAL TRIAL: CBT AUGMENTATION OF SSRI TREATMENT FOR GERIATRIC GAD

临床试验：CBT 强化 SSRI 治疗老年 GAD

• 批准号: 8166822
• 负责人: Julie L Wetherell
• 金额: $ 0.47万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN DIEGO
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-12-01 至 2010-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8166822
• 关键词: Clinical Trials; Cognitive Therapy; Computer Retrieval of Information on Scientific Projects Database; Disease remission; Elderly; Escitalopram; Funding; Generalized Anxiety Disorder; Goals; Grant; Institution; Maintenance; Multicenter Studies; Relapse; Research; Research Personnel; Resources; Source; United States National Institutes of Health; improved; neuropsychological; prevent; response

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. 56 week multicenter study on the efficacy of Cognitive-Behavioral Therapy as an augmentation and maintenance strategy for older adults with Generalized Anxiety Disorder who are partial or full responders to escitalopram and also on the efficacy of maintenance escitalopram to prevent relapse. Goals are to examine whether adding a course of CBT will increase remission rates and reult in sympotomatic response and improved neuropsychological functioning among older adults with GAD who are partial responders to escitalopram.

该副本是利用众多研究子项目之一 由NIH/NCRR资助的中心赠款提供的资源。子弹和 调查员（PI）可能已经从其他NIH来源获得了主要资金， 因此可以在其他清晰的条目中代表。列出的机构是 对于中心，这不一定是调查员的机构。 56周多中心研究认知行为疗法的疗效，作为对急诊症的普遍焦虑症的增强和维持策略的增强和维持策略，这些焦虑症是对依源富兰的部分或全部反应者，以及维持依他普兰的维持效果，以防止复发。 目标是检查添加CBT课程是否会提高缓解率并在共体性反应中提高缓解率，并改善患有依他普兰（Escitalopram）部分响应者的GAD的老年人的神经心理功能。